Annual report pursuant to Section 13 and 15(d)

Summary of significant accounting policies (Detail) - Amount of expense related to share-based payment arrangements

v2.4.0.6
Summary of significant accounting policies (Detail) - Amount of expense related to share-based payment arrangements (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Jul. 31, 2012
Jul. 31, 2011
Jul. 31, 2010
Share Based Compensation $ 719 $ 1,049 $ 1,170
Cost of Clinical Laboratory Services [Member]
     
Share Based Compensation 10 10 12
Research and Development Expense [Member]
     
Share Based Compensation 4 14 14
Selling, General and Administrative Expenses [Member]
     
Share Based Compensation $ 705 $ 1,025 $ 1,144